INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

82,042 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PK
Pai KathleenEVP, Chief People Officer
NABLN-able, Inc.
Tax withholding
F$28K
5,018 sh
Feb 4, 2026Feb 6, 2026
Page 1602 of 2052
← PrevNext →
traded Feb 4, 2026
+2d
SEC Form 4

Evidence

9
YJ
Younes Steven JCHIEF HUMAN RESOURCES OFFICER
LWLamb Weston Holdings, Inc.
Grant or award
A—
85.4K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Tax withholding
F$10K
1,781 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
TD
Turner William D.Chief Regulatory Officer
VERAVera Therapeutics, Inc.
Grant or award
A—
50.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
AI
Adler Michael IEVP, CTPO
NABLN-able, Inc.
Tax withholding
F$45K
7,976 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
CB
Crotty Dylan BramGroup President
SYKSTRYKER CORP
Grant or award
A—
9,978 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
BR
Boodhoo RoshanDirector
APACStoneBridge Acquisition II Corp
Grant or award
A—
25.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
CC
Crowley Michael ChristopherPresident, North America
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
LL
Lamb LawrenceEVP and CSO
INABIN8BIO, INC.
Grant or award
A—
72.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
CB
Craps Jan Eli BDirector, Executive Chair
LWLamb Weston Holdings, Inc.
Grant or award
A—
110.2K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
MF
Moghal Ahmed FarhanEVP, Chief Financial Officer
BKRBaker Hughes Co
Grant or award
A—
27.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
YJ
Younes Steven JCHIEF HUMAN RESOURCES OFFICER
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
KS
Klaus Andrew SCFO
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
693 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
SS
Stiles Spencer SPresident and COO
SYKSTRYKER CORP
Grant or award
A—
20.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
HL
Hess Janice L.Director
ESEESCO TECHNOLOGIES INC
Disposition to issuer
D$60.46
0 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
BR
Brenner RobertChief Medical Officer
VERAVera Therapeutics, Inc.
Grant or award
A—
50.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
WS
Wilks SylviaChief Supply Chain Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
HS
Hammock SamanthaEVP & Chief HR Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A—
84.9K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Tax withholding
F$8,497
1,512 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
CB
Craps Jan Eli BDirector, Executive Chair
LWLamb Weston Holdings, Inc.
Grant or award
A—
750.0K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Disposition to issuer
D$60.46
0 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
KW
Koh WilliamVP of Asia Pacific Region
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
407 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
AF
Abbasi FarazDirector
LKFNLAKELAND FINANCIAL CORP
Grant or award
A$1,304
21 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
SM
Schroeder MarcPRESIDENT, INTERNATIONAL
LWLamb Weston Holdings, Inc.
Grant or award
A—
85.4K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
FM
Fordyce MarshallDirector, PRESIDENT AND CEO
VERAVera Therapeutics, Inc.
Grant or award
A—
137.5K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
MS
Mohamed Mohideen Mahboob SubuhaniDirector
APACStoneBridge Acquisition II Corp
Grant or award
A—
25.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

9
MA
Morcos Assaad AVP, US Manufacturing
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
407 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
CC
Crowley Michael ChristopherPresident, North America
LWLamb Weston Holdings, Inc.
Grant or award
A—
85.4K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
TE
Tamayo Louis EdwardChief Financial Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
226.7K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

9
SM
Schroeder MarcPRESIDENT, INTERNATIONAL
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A$27K
115 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

7
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$263K
2,051 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

7
KM
Kim Joo MiCHIEF FINANCIAL OFFICER
QLYSQUALYS, INC.
Open-market sale · 10b5-1 plan
SELL$471K
3,648 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$79K
496 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

6
FD
Flammer Martina M.D.Chief Medical Officer
INSMINSMED Inc
Open-market sale · 10b5-1 plan
SELL$132K
869 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

5
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
646.7K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
WW
Wells Preston WendellVP, Chief Financial Officer
SYKSTRYKER CORP
Grant or award
A—
12.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
CL
Charlton Rebecca LSVP, Controller & CAO
BKRBaker Hughes Co
Grant or award
A—
5,201 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

5
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Grant or award
A$21K
89 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

5
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
260.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence